Rationale for contemporary antimicrobial treatment of Stenotrophomonas maltophilia: a narrative review
Background: Stenotrophomonas maltophilia is an opportunistic pathogen most commonly isolated from patients with complex/life-threatening disease or cystic fibrosis. Traditionally, when treatment is warranted, trimethoprim-sulfamethoxazole has been the agent of choice, alone or in combination with a...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2025-06-01
|
| シリーズ: | CMI Communications |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S295059092500023X |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|